The CovClear COVID-19 Rapid Antigen Test is a lower nasal swab test designed to detect active COVID-19 infections in 20 minutes. CovClear was engineered for a simple and easy at-home testing experience.

With a 96% sensitivity compared to a high-sensitivity RT-PCR test, CovClear™ is the most clinically sensitive at-home rapid antigen test authorized in Canada at the time of authorization.

The Covclear COVID-19 Rapid Antigen Test is manufactured in the United States by Empowered Diagnostics, LLC and was approved by Health Canada on November 26, 2021.

Product Information


The CovClear Rapid Antigen test is a lateral flow assay for the detection of extracted nucleocapsid protein antigens specific to SARS-CoV-2 in nasal swab specimens directly collected.

Simple to use with rapid results in minutes. High sensitivity, specificity and accuracy. Safety advantage with sealed vial protecting against live virus. No reader or cassette required, reducing cost and waste. Researched, developed & manufactured in the USA.

How to use video: click here

What's Included?

Lateral flow assay strips, Chase buffer ampules, Vials, Locking caps, Individually wrapped swabs, Instructions for use. The number of units in each order will reflect the amount of tests purchased.

"96% Sensitivity, 100% Specificity"

Unlike other rapid tests on the market today, the CovClear COVID-19 Rapid Antigen Test demonstrated 96% sensitivity and 100% specificity compared to a high-sensitivity RT-PCR test.

The CovClear COVID-19 Rapid Antigen Test is a lateral flow immunochromatographic assay intended for the qualitative detection of the nucleocapsid protein antigen from SARS-CoV-2 in nasal swab specimens that are self-collected by an individual 18 or older or are collected by an adult from an individual aged 2 years of age and older.

Read Health Canada Details

CRT Corporate / Bulk Supply Program

Reliable and accessible tests are essential in order to ensure workplace safety and provide employees and employers piece of mind.

Apply Now (250+ Tests)